Recent Advances in Stroke Screening

Dear Colleagues,

Stroke is the third-highest cause of death after heart disease and cancer. It is the second-highest cause of dementia and leading cause of permanent disability. With the increase in life expectancy throughout the world, based on the improvement of socio-economic conditions, this disease is expected to have important social and economic repercussions. The introduction of therapeutic approaches such as intravenous thrombolysis and thrombectomy has improved the prognosis of this disease. These interventions require adequate structures and must be performed quickly to allow for the rapid recovery of the neurological deficit because stroke is a time-dependent pathology.

The economic and human resource costs of dealing with this pathology are high; therefore, it is important to act on the prevention. This Special Issue aims to collect works dedicated to the recent advance in vascular pathology screening, especially for stroke disease. There are various approaches that try to identify the warning or screening signs of stroke: administration of questionnaires to identify the risk factors, as well as diagnostic ones using artificial intelligence (AI); biological markers and instrumental diagnostics such as new AI tools; epidemiological and socio-economic studies linked to modifiable factors such as dietary regimes or physical activities; possible prevention actions in subpopulations and genders predisposed to stroke; suggestion for guidelines for the management of the early diagnosis of stroke in adults and at a pediatric age considering the cardiovascular risk factors such as the increase in obesity in children. Stroke is associated with different risk factors of internal medicine cause, and the contributions for this Special Issue are of a multidisciplinary nature because the sharing of medical–scientific and clinical knowledge will enable the best possibilities to manage this disabling disease.

Dr. Lorenzo Lorusso
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• stroke
• screening
• prevention
• recent advances
• neurology
• internal medicine